Viridans streptococci bacteremia in children with malignancy: Relevance of species identification and penicillin susceptibility

Pediatric Infectious Disease Journal

Volumn 24, Issue 6, 2005, Pages 563-566

  Husain, Entesar ^a   Whitehead, Sue ^a   Castell, Annette ^a   Thomas, Eva E ^a   Speert, David P ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

Author keywords

Malignancy; Penicillin resistance; Viridans streptococci

Indexed keywords

CEFOTAXIME; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN DERIVATIVE; VANCOMYCIN;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; BONE MARROW TRANSPLANTATION; CANADA; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; SPECIES IDENTIFICATION; STREPTOCOCCUS ACIDOMINIMUS; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS SANGUINIS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEOPLASMS; PENICILLIN RESISTANCE; PENICILLINS; SPECIES SPECIFICITY; STREPTOCOCCAL INFECTIONS; VIRIDANS STREPTOCOCCI;

EID: 20544436718     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000164708.21464.03     Document Type: Article

References (12)

1. Gamis AS, Howells WB, DeSwarte-Wallace J, et al. α hemolytic streptococcal infections during intensive treatment for acute myeloid leukemia: a report from the Children's Cancer Group Study CCG-2891. J Clin Oncol. 2000;18:1845-1855.
2. Bochud PY, Eggiman P, Calandra T, et al. Bacteremia due to viridans Streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin Infect Dis. 1994;18:25-31.
3. Bruckner LB, Korones DN, Kamauchow T, et al. High incidence of penicillin resistance among α-hemolytic streptococci isolated from the blood of children with cancer. J Pediatr. 2002;140:20-26.
4. Westling K, Ljungman P, Thalme A, Julander I. Streptococcus viridans septicemia: a comparison study in patients admitted to the departments of infectious diseases and hematology in a university hospital. Scand J Infect Dis. 2002;4:316-319.
5. Marron A, Carratala J, Gonzalez-Barca E, et al. Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer. Clin Infect Dis. 2000;31:1126-1130.
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixth International Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 1995.
7. Richard P, Del Valle GA, Moreau P, et al. Viridans streptococcal bacteremia in patients with neutropenia. Lancet. 1995;345:1607-1608.
8. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci; a case-control study of predisposing factors. Clin Infect Dis. 1994;14:1201-1207.
9. Rabe LK, Winterscheid KK, Hillier SL. Association of viridans group streptococci from pregnant women with bacterial vaginosis and upper genital tract infection. J Clin Microbiol. 1988;26:1156-1160.
10. Takada H, Kaawabata Y, Tamura M, et al. Cytokine induction by extra cellular products of oral viridans streptococci. Infect Immun. 1993;61: 5252-5260.
11. Matsushita K, Fujimaki W, Kato H, et al. Immunopathological activities of extra cellular products of Streptococcus mitis, particularly a superantigenic fraction. Infect Immun. 1995;63:785-793.
12. Carratala J, Alcaide F, Fernandez-Sevilla A, et al. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin Infect Dis. 1994;20:1169-1167.